When bacteriostatic water is added to a lyophilized peptide vial, the peptide dissolves into solution and becomes metabolically active
The Vote and What It Means Despite internal objections from agency scientists, the PCAC voted 8-6 in favor of recommending BPC-157 for inclusion, specifically for use in treating ulcerative colitis
This suggests that the tumor cells make and store this DSIP-like substance before releasing it
The ideal schedule depends on a few key things: how well your body absorbs and uses B12, any underlying health conditions you might have, and even your daily habits
You should not take BPC-157 if: You have a personal or family history of cancer: BPC-157 cannot differentiate between healthy tissue and tumor cells
No guaranteed purity, sterility, or accurate dosing